JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

VEGFR

C3730 AAL-993

Summary: VEGF receptors inhibitor

≤1 mg/mL
C3415 Tivozanib (hydrate)

Summary: VEGFR inhibitor, orally available

≤25 mg/mL
C3342 MAZ51

Target: VEGFR

Summary: VEGFR3 antagonist

insoluble in EtOH; insoluble in H2O; ≥31.4 mg/mL
B7800 BAW2881 (NVP-BAW2881)

Summary: VEGFR inhibitor

≥42.4 mg/mL
B6746 SU 4312

Summary: VEGFR and PDGFR tyrosine kinases inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.45 mg/mL
B6199 BFH772

Summary: VEGFR2 inhibitor

≥53.4 mg/mL
B5953 Dovitinib (TKI258) Lactate

Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR

Summary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).

insoluble in EtOH; ≥10.62 mg/mL
B5864 Fruquintinib(HMPL-013)

Target: VEGFR

Summary: Potent and selective inhibitor of VEGFR 1, 2, 3

insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
B5835 AZD2932

Target: FLT3|VEGFR|PDGFR|c-Kit

Summary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit

Soluble in DMSO
B5611 DMH4
1 Citation

Summary: VEGFR-2 inhibitor

<20.02 mg/mL